Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin75.9%+1.4pp75.3%+1.5pp74.8%74%74.4%
Operating margin-60.5%+15.5pp-60.5%+28.3pp-58%-64.5%-76%
Net margin-57.8%+18.3pp-58.7%+30.6pp-57.5%-65.4%-76%
EBITDA margin-59.9%-60%-57.5%-64.1%
Free cash flow margin-61.1%-58.6%-63.7%-71.9%
Efficiency
Inventory turnover10.3×8.8×10.5×
Liquidity
Current ratio11.9×8.9×+3.3×12×4.9×
Quick ratio11.7×8.7×+3.3×11.9×4.8×
Cash ratio7.5×+1.5×10.6×3.5×
Leverage
Debt-to-equity0.2×0.2×0.2×
Debt-to-assets0.1×0.1×-0.2×0.1×0.3×
Interest coverage-24.7×-7.9×-21.4×-3.1×-17.6×-16.5×-16.8×
Per Share
Book value per share$3.44+119%$6.95+140%$5.06+131%-$18.10-27.1%-$17.82
Valuation
Market capitalization$305.56M-20.3%$328.42M$355.92M
Enterprise value$249.8M$260.04M$258.16M
Price / sales5.4×6.5×
Price / book3.3×3.3×3.3×
EV / sales4.4×5.1×5.8×
Free cash flow yield-11.3%-9%-8%
Earnings yield-10.7%-9%-7.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Carlsmed, Inc. Common Stock's profit margins?
Carlsmed, Inc. Common Stock (CARL) runs a 75.9% gross margin and a -60.5% operating margin, with a -57.8% net margin.
Where do Carlsmed, Inc. Common Stock's ratios come from?
Every ratio is computed from Carlsmed, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.